Gene therapy competitive dynamics: Winner takes all
With many gene therapies in development for an increasing number of indications, their curative promise presents a unique competitive dynamic as they enter the...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
With many gene therapies in development for an increasing number of indications, their curative promise presents a unique competitive dynamic as they enter the...
Under the US Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” of IP litigations between makers of branded small molecule...